|
TMCO7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.635200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.65159999999864E-05 |
| Normal-vs-Stage2 |
1.690590E-01 |
| Normal-vs-Stage3 |
3.059200E-01 |
| Normal-vs-Stage4 |
4.998300E-04 |
| Stage1-vs-Stage2 |
2.753200E-01 |
| Stage1-vs-Stage3 |
6.491900E-02 |
| Stage1-vs-Stage4 |
3.745200E-01 |
| Stage2-vs-Stage3 |
6.956200E-01 |
| Stage2-vs-Stage4 |
1.725370E-01 |
| Stage3-vs-Stage4 |
9.012400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.215300E-04 |
| Normal-vs-AfricanAmerican |
5.170300E-04 |
| Normal-vs-Asian |
9.244200E-01 |
| Caucasian-vs-AfricanAmerican |
4.739800E-01 |
| Caucasian-vs-Asian |
5.662600E-01 |
| AfricanAmerican-vs-Asian |
4.908600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17209999999746E-05 |
| Normal-vs-Female |
9.409500E-02 |
| Male-vs-Female |
1.260310E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.15949999998944E-06 |
| Normal-vs-Extreme_Weight |
1.6752999999925E-05 |
| Normal-vs-Obese |
1.334380E-02 |
| Normal-vs-Extreme_Obese |
4.821200E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.054800E-01 |
| Normal_Weight-vs-Obese |
2.050200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.922400E-01 |
| Extreme_Weight-vs-Obese |
3.337800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.224000E-01 |
| Obese-vs-Extreme_Obese |
2.455000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.664000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.636900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.978590E-04 |
| Normal-vs-Age(81-100Yrs) |
1.595190E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.651000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.845200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.201700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.145600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.743500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.303160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63603999999706E-05 |
| Normal-VS-Type2 PRCC |
2.921600E-02 |
| Normal-VS-KIRP CIMP |
4.559400E-01 |
| Normal-VS-Unclassified PRCC |
5.623800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.834100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.342770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.796200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.208800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.660400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.495400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.122100E-02 |
| Normal-vs-N1 |
6.882200E-02 |
| Normal-vs-N2 |
7.143400E-03 |
| N0-vs-N1 |
8.187000E-01 |
| N0-vs-N2 |
4.408000E-01 |
| N1-vs-N2 |
2.790400E-01 |
|
|
